Cargando…
Beta-Adrenergic Blockade in Critical Illness
Catecholamine upregulation is a core pathophysiological feature in critical illness. Sustained catecholamine β-adrenergic induction produces adverse effects relevant to critical illness management. β-blockers (βB) have proposed roles in various critically ill disease states, including sepsis, trauma...
Autores principales: | Bruning, Rebecca, Dykes, Hannah, Jones, Timothy W., Wayne, Nathaniel B., Sikora Newsome, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554196/ https://www.ncbi.nlm.nih.gov/pubmed/34721025 http://dx.doi.org/10.3389/fphar.2021.735841 |
Ejemplares similares
-
Beta adrenergic blockade reduces utilitarian judgement
por: Sylvia, Terbeck, et al.
Publicado: (2013) -
Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?
por: Embaby, Alaa, et al.
Publicado: (2022) -
Blockade of β-Adrenergic Receptors by Propranolol Disrupts Reconsolidation of Drug Memory and Attenuates Heroin Seeking
por: Chen, Liangpei, et al.
Publicado: (2021) -
Adrenergic Blockade by Nebivolol to Suppress Oral Squamous Cell Carcinoma Growth via Endoplasmic Reticulum Stress and Mitochondria Dysfunction
por: Chen, Qian, et al.
Publicado: (2021) -
Beta2-Adrenergic Receptor Polymorphisms and Haplotypes Associate With Chronic Pain in Sickle Cell Disease
por: Jhun, Ellie H., et al.
Publicado: (2019)